Understanding the New MedRxiv Preprint on Depression in South Africa

A groundbreaking study published on medRxiv has analyzed patterns of depression prevalence and antidepressant use across South Africa from 2002 to 2024, revealing remarkably stable rates of depression over more than two decades. Led by researchers from the University of the Witwatersrand's Developmental Pathways for Health Research Unit, this system dynamics modeling effort synthesizes national survey data, pharmaceutical sales, and health service records to provide the most comprehensive view yet of mental health trends in the country. The findings underscore persistent challenges in access to care, even as antidepressant prescriptions have slowly risen.

The research highlights depression as South Africa's leading cause of disability, affecting productivity, relationships, and overall well-being. By integrating diverse datasets, the authors offer insights into why prevalence has held steady despite economic shifts, the HIV epidemic, and the COVID-19 pandemic, which temporarily spiked symptoms in many regions.

Historical Context of Depression Burden in South Africa

Depression, or major depressive disorder (MDD), a mood disorder characterized by persistent sadness, loss of interest, and impaired daily functioning, has long plagued South Africa. Lifetime prevalence estimates from earlier surveys like the South African Stress and Health study hovered around 9.7%, with 12-month rates at 4.9%. Rural areas report even higher symptomatic rates, up to 27% in some communities.

Post-apartheid socioeconomic inequalities, unemployment peaking at 32% in 2024, and the HIV/AIDS crisis—where South Africa has the world's largest burden—exacerbate risks. Women face 1.5-2 times higher odds, linked to gender-based violence affecting one in three. Youth, comprising 66% under 35, show probable depression rates of 30% in recent adolescent studies.

How Researchers Modeled Two Decades of Data

The study employs system dynamics modeling, a method that simulates complex interactions over time using stocks (e.g., depressed population), flows (incidence, recovery), and feedback loops (treatment effects). Data sources include:

• South African National Health and Nutrition Examination Surveys (SANHANES) for prevalence screening via Patient Health Questionnaire-9 (PHQ-9).
• Pharmaceutical sales from IQVIA for antidepressant dispensing.
• General Household Surveys and District Health Information System for service utilization.

Models calibrated incidence at 4-5% annually, remission influenced by treatment (20-40% faster with antidepressants), and mortality risks 1.5-fold higher in untreated cases. Projections account for population growth from 44 million in 2002 to 63 million in 2024.

Stable Depression Prevalence: Key Trends 2002-2024

Overall adult depression prevalence remained stable at approximately 4.5% (95% CI: 4.0-5.0%) throughout the period. In 2024, it stood at 4.5%, with no significant upward or downward trajectory despite stressors like the 2008 financial crisis and COVID-19 lockdowns that increased probable depression to 38% in some surveys.

Stability arises from balancing higher incidence in vulnerable groups with improved spontaneous remission and under-detection. Peaks occurred around 2010 (HIV zenith) and 2020 (pandemic), but normalized by 2022. Rural-urban divide persists: 5.2% rural vs. 4.1% urban.

Rising Yet Insufficient Antidepressant Use

Antidepressant use climbed from 1.0% (95% CI: 0.8-1.2%) in 2008 to 2.8% (2.2-3.4%) in 2024 among adults—a 180% increase but still far below global averages of 7-10%. Selective serotonin reuptake inhibitors (SSRIs) like escitalopram and sertraline dominate, reflecting WHO essential medicines list adoption.

Annual Defined Daily Doses per 1,000 population rose from 10 in 2002 to 28 in 2024, driven by private sector growth. However, only 30% of prevalent cases receive treatment, leaving a 70% gap.

Photo by Marcel Strauß on Unsplash

Demographic Disparities: Who Is Most Affected?

Women consistently show higher prevalence: 5.3% (4.7-5.9%) vs. men's 3.6% (3.2-4.0%) in 2024. Age gradient peaks at 60+: 6.8% (5.9-7.8%), due to multimorbidity and isolation. Black Africans (largest group) at 4.8%, Coloured 4.2%, White 3.9%.Read the full study

• Low-income quintiles: 5.5-6.0%
• Unemployed: 7.2% prevalence
• HIV-positive: 2x risk

Students at universities like Wits report 21-45% probable depression, linked to financial stress and academic pressure.

Stark Public-Private Sector Inequalities

The divide is glaring: 2024 private sector use 11.0% (8.8-13.5%) vs. public 0.9% (0.7-1.1%). Public facilities, serving 80% of population, lack psychiatrists (1 per 100,000 vs. global 4).SAHR report on shortages Medical aids cover 16%, skewing access to urban elites.

Implications: Untreated depression costs R160 billion annually in lost productivity. Universities feel this: 37% students meet anxiety/depression criteria, straining counseling services.

Implications for University Students and Staff

Higher education mirrors national trends: Wits' study on Johannesburg students found 47% probable depression screening positive, tied to NSFAS delays and fees.Explore South Africa academic jobs First-years at rural unis like Walter Sisulu report 40%+ distress.

Academics face burnout: depression impairs research output. Wits researchers like Leigh Johnson emphasize screening integration in student health. Faculty positions demand resilient staff; mental health support boosts retention.

Policy Responses and Bridging the Treatment Gap

South Africa's 92% treatment gap demands action: National Mental Health Policy (2023) prioritizes task-sharing—nurses prescribing antidepressants. Yet, only 5% public budget for mental health vs. WHO's 12%.

• Expand primary care integration (mhGAP)
• Digital therapy apps like SADAG's toll-free line
• University partnerships for peer counseling

NHI rollout could equalize access, modeling private sector success.Mental Health Situational Analysis

University-Led Initiatives and Innovations

South African universities lead: UCT's Rate My Professor forums discuss wellness; Stellenbosch offers free counseling. Wits' Pathways Unit drives evidence-based interventions. Post-COVID, hybrid telepsychiatry reduced no-shows by 25%.

AI chatbots at UWC promise scalable support for 1 million students. Career advice via higher ed career advice includes resilience training.

Photo by Marcel Strauß on Unsplash

Future Outlook: Pathways to Improvement

Projections: Without intervention, prevalence stable but absolute cases rise with population. Doubling public dispensing could close gap to 50% by 2030. Universities key: training psychologists (only 20 per million), research funding via NRF.

Optimism from rising awareness—SADAG helpline calls up 40% post-2020. Equitable access via NHI and uni expansions could transform outcomes.

Actionable Steps for Stakeholders

For students: Seek campus clinics early; use SADAG 0800 567 567. Academics: Prioritize self-care for productivity. Policymakers: Fund task-sharing. Explore university jobs in mental health research. Share experiences on Rate My Professor.

This study spotlights urgency: stable rates mask unmet need. Collaborative efforts promise progress.